House
John Abney Culberson
—
Transactions
6
Total transactions associated with this filer
Disclosed purchases
3
$3.0K – $45.0K
Average modeled return
+1027.1%
2 of 3 purchases modeled
Average vs. S&P 500
+759.6%
Comparable modeled intervals
MODELED PERFORMANCE
Disclosed purchases vs. S&P 500
2 most recent modeled purchases. The summary and table include all modeled purchases.
MARKET ANALYSIS
Modeled purchase performance · Since purchase
2 of 3 disclosed purchases have modeled returns for this period. 1 purchases have missing or excluded market data; no returns are invented for them.
DISCLOSED ACTIVITY
Recent transaction history
Showing up to 25 records per page · Page 1 of 1 · 6 total transactions
| Ticker↑↓ | Asset↑↓ | Date↑↓ | Type↑↓ | Disclosed amount↑↓ | Source |
|---|---|---|---|---|---|
| — | Innate Immunotherapeutic | Jan 26, 2017 | purchase | $1.0K – $15.0K | Filing ↗ |
| — | Inmate Immunotherapeutic | Jun 12, 2017 | sale | $1.0K – $15.0K | Filing ↗ |
| AAPL | Apple Inc. | Aug 13, 2018 | sale | $15.0K – $50.0K | Filing ↗ |
| AAPL | Apple Inc. | Aug 29, 2018 | sale | $15.0K – $50.0K | Filing ↗ |
| AAPL | Apple Inc. | Jan 25, 2017 | purchase | $1.0K – $15.0K | Filing ↗ |
| AAPL | Apple Inc. | Apr 3, 2017 | purchase | $1.0K – $15.0K | Filing ↗ |
ANNUAL REPORTING
Annual financial disclosures
| Year | Document | Assets parsed | Status | Source |
|---|
No annual disclosure is currently associated with this filer.
Modeled market performance is calculated from public disclosure dates and historical market prices. It does not represent verified execution prices, realized investment returns, or investment advice. Read the modeling methodology · Review data sources and coverage · Explore other politicians